Work

Graft versus host desease as a rare and seriously side effect of anti-PD-1 inhibitor immunotherapy

Year: 2025

Type: article

Abstract: Background: With the introduction of anti-PD-1 immunotherapies, a modern and highly effective therapeutic option opened up for us. However, due to the enhancement of T-cell activity, we can count on the appearance of various immune-related side effects.

Source: EJC Skin Cancer

DOI: 10.1016/j.ejcskn.2025.100577

Authors: C. Hanis, T. Balatoni, K. Czirbesz, M. Kispál, T. Danyi

Institution: National Institute of Oncology

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,340